Home> Products> Inhibitors> 9-Hydroxyellipticine Hydrochloride-CAS 52238-35-4
price inquiry for CAS:52238-35-4, Product:9-Hydroxyellipticine Hydrochloride
For research use only. We do not sell to patients.

9-Hydroxyellipticine Hydrochloride CAS: 52238-35-4

Category: Inhibitors
Product Name: 9-Hydroxyellipticine Hydrochloride
Cat No: I000124
CAS No: 52238-35-4
Molecular Formula: C17H14N2O
Molecular Weight: 262.31
SMILES: OC1=CC2=C(NC3=C2C(C)=C(C=NC=C4)C4=C3C)C=C1.[H]Cl
InChI: InChI=1S/C17H14N2O.ClH/c1-9-14-8-18-6-5-12(14)10(2)17-16(9)13-7-11(20)3-4-15(13)19-17;/h3-8,19-20H,1-2H3;1H
Solubility: Soluble in DMSO, not in water
CAS 52238-35-4,9-Hydroxyellipticine Hydrochloride
  • Description

9-Hydroxyellipticine Hydrochloride(cas 52238-35-4), also known as IGIG 929 and LS133324, is a potent cytotoxic and antitumor agent. Structurally, 9-hydroxyellipticine is a 9-hydroxy derivative of ellipticine. 

  • Spec

Appearance:Solid powder
Purity: > 98%

  • References

1: Saeki K, Obi I, Ogiku N, Shigekawa M, Imagawa T, Matsumoto T. Cardioprotective effects of 9-hydroxyellipticine on ischemia and reperfusion in isolated rat heart. Jpn J Pharmacol. 2002 May;89(1):21-8. PubMed PMID: 12083739.
2: Sugikawa E, Tsunoda S, Nakanishi N, Ohashi M. 9-Hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein. Anticancer Res. 2001 Jul-Aug;21(4A):2671-5. PubMed PMID: 11724337.
3: Ohashi M, Sugikawa E, Nakanishi N. Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism. Jpn J Cancer Res. 1995 Sep;86(9):819-27. PubMed PMID: 7591958.
4: Braham Y, Meunier G, Meunier B. [Demonstration of an oxidative biotransformation of 9-methoxyellipticine. Comparison with the case of 9-hydroxyellipticine]. C R Acad Sci III. 1987;304(11):301-6. French. PubMed PMID: 3103875.

price inquiry for CAS:52238-35-4, Product:9-Hydroxyellipticine Hydrochloride